Brooklyn Investment Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Buy
30,837
+1,307
+4% +$116K 0.08% 208
2025
Q4
$2.35M Buy
29,530
+22,276
+307% +$1.75M 0.11% 151
2025
Q3
$643K Sell
7,254
-735
-9% -$62.7K 0.09% 225
2025
Q2
$726K Buy
7,989
+2,954
+59% +$270K 0.1% 212
2025
Q1
$472K Sell
5,035
-529
-10% -$47.4K 0.1% 188
2024
Q4
$506K Buy
5,564
+405
+8% +$38.6K 0.15% 120
2024
Q3
$536K Buy
5,159
+406
+9% +$41.4K 0.18% 107
2024
Q2
$423K Hold
4,753
0.18% 125
2024
Q1
$423K Sell
4,753
-169
-3% -$14.3K 0.18% 125
2023
Q4
$392K Buy
+4,922
New +$370K 0.19% 123

Other funds holding CL

Brooklyn Investment Group's CL Position: Q1 2026 in Review

Brooklyn Investment Group increased its Colgate-Palmolive (CL) stake by 4.4% in Q1 2026, buying an estimated $116K and bringing the position to 30,837 shares worth $2.63M. The position accounts for 0.08% of the portfolio, ranked #208.

Brooklyn Investment Group first reported a position in CL in Q4 2023 and has held it in 10 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Brooklyn Investment Group held 30,837 shares of Colgate-Palmolive worth $2.63M as of Q1 2026.
  • Brooklyn Investment Group bought 1,307 Colgate-Palmolive shares in Q1 2026, an estimated $116K.
  • Colgate-Palmolive made up 0.08% of Brooklyn Investment Group's portfolio in Q1 2026, its #208 holding.
  • Brooklyn Investment Group first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 10 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.